Cybin (HELP) Operating Income (2020 - 2021)

Cybin (HELP) reported Operating Income of -$9.8 million for Q1 2021, down 11.92% quarter-over-quarter from -$8.7 million in Q4 2020.

Cybin (HELP) Operating Income (2020 - 2021) Analysis & Trends

Cybin has reported Operating Income for 2 years, with the latest figure at -$9.8 million in Q1 2021.

For the quarter ending Q1 2021, Operating Income changed N/A year-over-year to -$9.8 million; the trailing twelve-month figure through Mar 2021 stood at -$23.5 million (changed N/A YoY), and the FY2021 full-year result was -$24.1 million, changed N/A from the prior year.
Operating Income for Q1 2021 stood at -$9.8 million, down from -$8.7 million in the prior quarter.
The five-year high for Operating Income was -$1.9 million in Q3 2020, with the low at -$9.8 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Op. Inc (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-32.68 Mn
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-2.97 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-19.70 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-3.82 Mn
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-15.76 Mn
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	1.14 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	-65.83 Mn
10	Cybin	75.42 Mn	75.42 Mn	-	-

Download Data